Insulet Corporation (PODD)
- Previous Close
177.53 - Open
179.41 - Bid 163.89 x 200
- Ask 188.08 x 200
- Day's Range
171.66 - 193.30 - 52 Week Range
125.82 - 331.65 - Volume
1,133,777 - Avg. Volume
880,338 - Market Cap (intraday)
12.053B - Beta (5Y Monthly) --
- PE Ratio (TTM)
51.54 - EPS (TTM)
3.34 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
234.90
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
www.insulet.comRecent News: PODD
Performance Overview: PODD
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PODD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PODD
Valuation Measures
Market Cap
12.43B
Enterprise Value
13.08B
Trailing P/E
60.38
Forward P/E
62.11
PEG Ratio (5yr expected)
3.19
Price/Sales (ttm)
7.70
Price/Book (mrq)
16.97
Enterprise Value/Revenue
7.74
Enterprise Value/EBITDA
40.61
Financial Highlights
Profitability and Income Statement
Profit Margin
13.14%
Return on Assets (ttm)
6.74%
Return on Equity (ttm)
36.18%
Revenue (ttm)
1.78B
Net Income Avi to Common (ttm)
234M
Diluted EPS (ttm)
3.34
Balance Sheet and Cash Flow
Total Cash (mrq)
751.2M
Total Debt/Equity (mrq)
177.25%
Levered Free Cash Flow (ttm)
--
Research Analysis: PODD
Company Insights: PODD
PODD does not have Company Insights